insurance that covers glp-1 coverage just changed for as many as 56 million Americans when it comes to the popular medications used to promote weight loss. Link in comments ⬇️ My Insurance Won't Cover GLP-1

Cardiovascular Outcomes Data Favors Semaglutide For Now The SELECT trial (published in the New England Journal of Medicine in 2023) demonstrated that semaglutide reduced major adverse cardiovascular events by 20% in patients with obesity and established cardiovascular disease

Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells

Dietary and Lifestyle Recommendations: Key Takeaways Protein Intake : Adequate protein intake is critical for maintaining muscle mass during weight loss, especially for individuals on GLP-1 agonists, as appetite suppression effects may inadvertently lead to lower calorie and protein consumption

Jun 2007;177(6):2179-2184